These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Leprosy, a neurologic disease]. Coeytaux A; Truffert A; Mueller Y; Antille C; Jackson Y Rev Med Suisse; 2007 May; 3(110):1178, 1180-4. PubMed ID: 17564345 [TBL] [Abstract][Full Text] [Related]
7. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy. Spierings E; De Boer T; Zulianello L; Ottenhoff TH Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869 [TBL] [Abstract][Full Text] [Related]
8. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033 [TBL] [Abstract][Full Text] [Related]
9. Leprosy: a 'common' and curable cause of peripheral neuropathy with skin lesions. Breen DP; Deeb J; Vaidya S; Lockwood DN; Radunovic A J R Coll Physicians Edinb; 2015 Mar; 45(1):38-42. PubMed ID: 25874829 [TBL] [Abstract][Full Text] [Related]
10. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT. Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569 [TBL] [Abstract][Full Text] [Related]
11. Nerve damage in leprosy. Job CK Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):532-9. PubMed ID: 2545801 [No Abstract] [Full Text] [Related]
12. Neuritic leprosy: further progression and significance. Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK Acta Leprol; 1995; 9(4):187-94. PubMed ID: 8711979 [TBL] [Abstract][Full Text] [Related]
13. Nerve damage in leprosy and its management. Wilder-Smith EP; Van Brakel WH Nat Clin Pract Neurol; 2008 Dec; 4(12):656-63. PubMed ID: 19002133 [TBL] [Abstract][Full Text] [Related]
14. Late onset neuropathy in leprosy patients released from treatment: not all due to reactions? Cardoso Fde M; De Freitas MR; Escada TM; Nevares MT; Nascimento OJ Lepr Rev; 2013 Jun; 84(2):128-35. PubMed ID: 24171238 [TBL] [Abstract][Full Text] [Related]
16. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience. Sheetal S; Arvind C Int J Rheum Dis; 2009 Apr; 12(1):64-9. PubMed ID: 20374320 [TBL] [Abstract][Full Text] [Related]
17. Leprous neuropathy. de Freitas MR; Said G Handb Clin Neurol; 2013; 115():499-514. PubMed ID: 23931798 [TBL] [Abstract][Full Text] [Related]
18. Challenges presented by nerve damage in leprosy. Harboe M; Aseffa A; Leekassa R Lepr Rev; 2005 Mar; 76(1):5-13. PubMed ID: 15881032 [TBL] [Abstract][Full Text] [Related]
20. Severe peripheral neuropathy following HAART initiation in an HIV-infected patient with leprosy. Pavie J; De Castro N; Molina JM; Flageul B J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):232-5. PubMed ID: 20798403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]